You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vidaza

Showing 1 - 25 of 271
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia(CLL)
  • Small Lymphocytic Lymphoma
  • Hackensack, New Jersey
    Hackensack University Medical Center
Jun 24, 2022

Recurrent Ependymoma Trial in Houston (5-Azacytidine (5-AZA) group 1, 5-Azacytidine (5-AZA) group 2, 5-Azacytidine (5-AZA) group

Recruiting
  • Recurrent Ependymoma
  • 5-Azacytidine (5-AZA) group 1
  • +2 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Aug 17, 2022

Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Combination 5-azacytidine and nivolumab
  • +2 more
  • (no location specified)
Dec 7, 2022

MDS, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Australia (Azacitidine, CC-486)

Active, not recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Newcastle, New South Wales, Australia
  • +10 more
Mar 29, 2022

Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

Recruiting
  • Recurrent IDH1/2 Mutated Glioma
  • Paris, France
    Pitie Salpetriere Hospital
Aug 29, 2022

GVHD Trial in Hackensack (Cyclophosphamide and Sirolimus, Low dose IL-2 with Cytoxan + Sirolimus, Low dose IL-2, low dose

Terminated
Has Results
  • Graft Versus Host Disease
  • Cyclophosphamide and Sirolimus
  • +3 more
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Feb 4, 2022

Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)

Active, not recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Irving Medical Center
Nov 29, 2022

Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2023

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Recruiting
  • Acute Bilineal Leukemia
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

Acute Myelocytic Leukemia, Myelodysplastic Syndrome Trial in Germany (Azacitidine)

Completed
  • Acute Myelocytic Leukemia
  • Myelodysplastic Syndrome
  • Berlin, Germany
  • +10 more
Nov 12, 2021

Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)

Not yet recruiting
  • Leukemia, Juvenile Myelomonocytic
  • +4 more
  • (no location specified)
May 4, 2023

Hodgkin's Lymphoma Trial in Houston (Azacytidine, Pembrolizumab)

Recruiting
  • Hodgkin's Lymphoma
  • Houston, Texas
    MD Anderson Cancer Center
Oct 5, 2022

Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 21, 2023

Acute Myeloid Leukemia, Relapsed Adult AML Trial (Lintuzumab-Ac225, Venetoclax, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Relapsed Adult AML
  • Lintuzumab-Ac225
  • +2 more
  • (no location specified)
Feb 22, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • DSP107
  • +2 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center, Department of
Nov 13, 2022

Acute Kidney Disease Trial in Taipei City (Azacitidine, Placebo)

Not yet recruiting
  • Acute Kidney Disease
  • Taipei City, Taiwan
    Yu Hsiang Chou
May 2, 2022

MDS Trial in Saint Louis (vosaroxin, Azacitidine)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 23, 2022

Acute Myelogenous Leukemia AML, Myelodysplastic Syndrome MDS Trial in Maywood (Vidaza and Valproic Acid)

Recruiting
  • Acute Myelogenous Leukemia AML
  • Myelodysplastic Syndrome MDS
  • Vidaza and Valproic Acid
  • Maywood, Illinois
    Loyola University Cardinal Bernardin Cancer Center
Apr 23, 2021

Myelodysplastic Syndrome Trial in France (Azacitidine)

Completed
  • Myelodysplastic Syndrome
  • Amiens, France
  • +20 more
Dec 24, 2021

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 31, 2022

Leukemia, Myeloid, Acute Trial (Cytarabine, Venetoclax, CPX-351)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • (no location specified)
Nov 25, 2022

Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Myelofibroses
  • Chicago, Illinois
    The University of Chicago
May 16, 2022

High Risk Myelodysplastic Syndrome, IPSS Risk Category Intermediate-1, Myelodysplastic Syndrome Trial in Houston (Azacitidine,

Active, not recruiting
Has Results
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Leukemia Trial in Houston (Brentuximab Vedotin, 5-Azacytidine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 7, 2022